Showing results (1261-1270 of 1,344) with videos related to
Sort By:
Pageof 135
The Pharmacogenomics Journal|December 14, 2011
How informative is a negative finding in a small pharmacogenetic study?S-A Bacanu, J C Whittaker, M R NelsonThe Pharmacogenomics Journal|May 16, 2012
Possible association of CUX1 gene polymorphisms with antidepressant response in major depressive disorderD Sasayama, A Hiraishi, M Tatsumi, et al.The Pharmacogenomics Journal|May 16, 2012
Profiling of drug-metabolizing enzymes/transporters in CD33+ acute myeloid leukemia patients treated with Gemtuzumab-Ozogamicin and Fludarabine, Cytarabine and IdarubicinI Iacobucci, A Lonetti, A Candoni, et al.The Pharmacogenomics Journal|May 30, 2012
Predicting inhaled corticosteroid response in asthma with two associated SNPsM J McGeachie, A C Wu, H-H Chang, et al.The Pharmacogenomics Journal|June 6, 2012
RYR3 gene polymorphisms and cardiovascular disease outcomes in the context of antihypertensive treatmentA I Lynch, M R Irvin, E Boerwinkle, et al.The Pharmacogenomics Journal|September 4, 2013
Germline genetic variants in ABCB1, ABCC1 and ALDH1A1, and risk of hematological and gastrointestinal toxicities in a SWOG Phase III trial S0221 for breast cancerS Yao, L E Sucheston, H Zhao, et al.The Pharmacogenomics Journal|May 15, 2013
Gene-expression differences in peripheral blood between lithium responders and non-responders in the Lithium Treatment-Moderate dose Use Study (LiTMUS)R D Beech, J J Leffert, A Lin, et al.The Pharmacogenomics Journal|July 17, 2013
Association of a complement receptor 1 gene variant with baseline erythrocyte sedimentation rate levels in patients starting anti-TNF therapy in a UK rheumatoid arthritis cohort: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohortJ Bluett, I Ibrahim, D Plant, et al.The Pharmacogenomics Journal|March 20, 2013
A genome-wide association study of bronchodilator response in asthmaticsQ L Duan, J Lasky-Su, B E Himes, et al.The Pharmacogenomics Journal|April 3, 2013
Genetic variants associated with methotrexate efficacy and toxicity in early rheumatoid arthritis: results from the treatment of early aggressive rheumatoid arthritis trialS Aslibekyan, E E Brown, R J Reynolds, et al.Pageof 135